Stomach
| TREATMENT REGIMENS | |||||
|---|---|---|---|---|---|
| Neoadjuvant and Adjuvant | |||||
| FLOT | |||||
| ECF | |||||
| Advanced or metastatic disease | |||||
| Trastuzumab + cisplatin + fluorouracil or capecitabine | |||||
| EOX | |||||
| DCF | |||||
| Palliative ECF | |||||
| Ramucirumab + paclitaxel | |||||
| FOLFIRI - RMH | |||||
| Trifluridine + tipiracil | |||||
| TREATMENT REGIMENS | |||||
|---|---|---|---|---|---|
| Neoadjuvant and Adjuvant | |||||
| FLOT | |||||
| ECF | |||||
| Advanced or metastatic disease | |||||
| Trastuzumab + cisplatin + fluorouracil or capecitabine | |||||
| EOX | |||||
| DCF | |||||
| Palliative ECF | |||||
| Ramucirumab + paclitaxel | |||||
| FOLFIRI - RMH | |||||
| Trifluridine + tipiracil | |||||
Groupe d'étude en oncologie du Québec